
15 September 2021 | Meritics Ltd
Bioanalytical Protein-Protein Detection with the P4SPR
Approximately one in five women diagnosed with breast cancer worldwide will have HER2-positive breast cancer, a particularly aggressive form of the disease.
Although four diagnostic tests exist, research has shown that some HER2 status test results may still be wrong.A diagnostic test using SPR may help address some of the current issues.
The potential biosensing application of a new ultra-low fouling ionic liquid is demonstrated using the P4SPR for the analysis of HER2 in breast cancer cell lysates.